The aim of this survey is to understand the impact that the current COVID-19 pandemic is having on pricing, reimbursement and market access for pharmaceutical manufacturers and biotech's.

We would very much appreciate it if you could spare 2-3 minutes to complete the survey by end of business 18/04/2020.

At the end of this survey, if you provide your email address we would be delighted to share with you the results of the survey.

Question Title

* 1. What impact is COVID-19 having on your company today?

Question Title

* 2. For your existing products, what impact has COVID-19 had on …

  No impact Low impact Medium impact Significant impact N/A
Price?
Market Access?
Uptake?

Question Title

* 3. What impact has COVID-19 had on your new pipeline products?

  No impact Low impact Medium impact Significant impact N/A
Clinical trials/evidence generation programs?
Ongoing pricing and market access projects?
Ability to begin/initiate new pricing and market access projects?
Time to market?
Other?
N/A

Question Title

* 4. If your pipeline products are delayed due to COVID-19, by approximately how many months do you anticipate the delay?

Question Title

* 5. If your pipeline products are delayed due to COVID-19, please state what the delays have been?

Question Title

* 6. If you have products currently undergoing national P&R/HTA assessment in the EU, what impact has COVID-19 had?

Question Title

* 7. What impact has COVID-19 had on your pricing and market access department/team?

Question Title

* 8. What do you see as your major challenge for the business resulting from COVID-19, if any?

Question Title

* 9. What impact do you think COVID-19 will have on the future payer/HTA and pricing landscape in the EU in the next 1-3 years?

  No impact Low impact Medium impact Significant impact N/A
Price?
National market access/HTA assessments?
Regional/local market access?

Question Title

* 10. What are the reasons why you expect these changes to the PMA landscape?

Question Title

* 11. Please use this comment box to raise other COVID-19-related topics that you'd like us to be aware of.

Question Title

* 12. Please provide your email address if you would like us to share the results of the survey with you

0 of 12 answered
 

T